Biodesix, Inc. (BDSX)

NASDAQ: BDSX · IEX Real-Time Price · USD
1.50
+0.25 (20.00%)
At close: Oct 4, 2022 4:00 PM
1.55
+0.05 (3.33%)
After-hours: Oct 4, 2022 7:56 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018
Revenue
54.5145.5624.5520.43
Revenue Growth (YoY)
19.64%85.55%20.16%-
Cost of Revenue
30.52226.074.41
Gross Profit
23.9923.5618.4816.03
Selling, General & Admin
50.5234.8630.6425.9
Research & Development
12.7910.8210.478.19
Operating Expenses
63.3145.6841.1134.09
Operating Income
-39.32-22.12-22.63-18.06
Interest Expense / Income
4.517.63.012.92
Other Expense / Income
-0.671.635.095.19
Pretax Income
-43.16-31.35-30.73-26.17
Net Income
-43.16-31.35-30.73-26.17
Net Income Common
-43.16-31.35-30.73-26.17
Shares Outstanding (Basic)
27500
Shares Outstanding (Diluted)
27500
Shares Change
465.63%1899.17%21.00%-
EPS (Basic)
-1.58-6.48-126.97-130.83
EPS (Diluted)
-1.58-6.48-126.97-130.83
Free Cash Flow Per Share
-1.12-4.87-95.63-91.47
Gross Margin
44.00%51.70%75.30%78.40%
Operating Margin
-72.10%-48.50%-92.20%-88.40%
Profit Margin
-79.20%-68.80%-125.10%-128.10%
Free Cash Flow Margin
-56.50%-51.70%-94.30%-89.50%
EBITDA
-35.47-20.84-24.93-21.51
EBITDA Margin
-65.10%-45.80%-101.50%-105.30%
Depreciation & Amortization
3.182.92.791.74
EBIT
-38.65-23.75-27.72-23.25
EBIT Margin
-70.90%-52.10%-112.90%-113.80%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).